Kelyniam Global Releases Q3 Financials, Strong Performance Continues

CANTON, Conn., Nov. 11, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for the third quarter ended September 30, 2024. 

"Kelyniam has consistently delivered strong performance year on year," said Ross Bjella, CEO of Kelyniam. "Our unwavering focus on overnight service and quality has been reflected in our third-quarter results."

Financial Highlights (Nine months ended September 30, 2024, vs. September 30, 2023)

Total Revenue: $2,492,607, up 43% from $1,741,587

Gross Margin: $1,956,714, up 44% from $1,349,684

Operating Profit: $273,248, compared to a loss of ($329,993), marking an improvement ...